The long term objectives of this grant application are to characterize the basic transport mechanisms in hepatocytes and bile duct epithelial cells (cholangiocytes) that determine the secretion of bile and to define the alterations in mechanisms that result in the development of cholestatic liver disease.
The specific aims of this proposal are: A) To study the transcriptional and post-transcriptional regulation of those membrane transport systems that are important to the formation of bile and that are impaired in cholestatic liver injury. Several animal models of cholestasis (endotoxemia, estrogen administration and bile duct ligation) will be used to examine the transcriptional and post-transcriptional changes that occur with several cloned transporters that are determinants of bile secretion (ntcp.mrp2 and mdrl). Gel mobility shift assays will be used to examine the regulatory elements for the promoter region of ntcp. B) To determine the role that the transcytotic vesicular pathway plays in the establishment of cell polarity and canalicular membrane excretory capacity, the protein composition of microtubule associated vesicles isolated by Taxol polymerization will be assessed using Western blots and gold labeling to identify the canalicular transporters and regulatory (rab) proteins that traffic together. Isolated hepatocyte couplets will be used to study the effects of protein kinases, phosphatases and PI-kinases on the regulation of vesicle traffic between subapical and apical regions of the hepatocyte C) To determine the functional role of membrane transport systems in cholangiocytes that modify the final bile secretory product, novel bile duct units isolated from normal rats and mice and CFTR(-/-) and NHE-3(-/-) mice will be used to access transport mechanisms in cholangiocytes including signal transduction pathways and synergism between secretory agonists as well as the role of the NK2CL co-transporter in secretory events. Newly developed isolated perfused duct segments will also be used to directly assess bile duct luminal events in the intact epithelium.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK025636-25
Application #
6380425
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Serrano, Jose
Project Start
1978-09-01
Project End
2003-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
25
Fiscal Year
2001
Total Cost
$690,693
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Yu, Dongke; Cai, Shi-Ying; Mennone, Albert et al. (2018) Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents. Liver Int 38:1128-1138
Pan, Qiong; Zhang, Xiaoxun; Zhang, Liangjun et al. (2018) Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis. Gastroenterology 155:1578-1592.e16
Li, Man; Cai, Shi-Ying; Boyer, James L (2017) Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med 56:45-53
Cai, Shi-Ying; Boyer, James L (2017) Studies on the mechanisms of bile acid initiated hepatic inflammation in cholestatic liver injury. Inflamm Cell Signal 4:
Kulkarni, Supriya R; Soroka, Carol J; Hagey, Lee R et al. (2016) Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis. Hepatology 64:2151-2164
Chai, Jin; Cai, Shi-Ying; Liu, Xiaocong et al. (2015) Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis. J Hepatol 63:1440-8
Li, Man; Mennone, Albert; Soroka, Carol J et al. (2015) Na(+) /H(+) exchanger regulatory factor 1 knockout mice have an attenuated hepatic inflammatory response and are protected from cholestatic liver injury. Hepatology 62:1227-36
Wheeler, Sadie G; Hammond, Christine L; Jornayvaz, François R et al. (2014) Ost?-/- mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity. Am J Physiol Gastrointest Liver Physiol 306:G425-38
Soroka, Carol J; Boyer, James L (2014) Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations. Mol Aspects Med 37:3-14
Ghonem, Nisanne S; Ananthanarayanan, Meenakshisundaram; Soroka, Carol J et al. (2014) Peroxisome proliferator-activated receptor ? activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion. Hepatology 59:1030-42

Showing the most recent 10 out of 137 publications